Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection
- PMID: 15216458
- DOI: 10.1086/422036
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection
Abstract
Background: Infection with primary drug-resistant human immunodeficiency virus type 1 (HIV-1) has been associated with higher CD4(+) T cell counts in drug-naive patients, suggesting that altered viral pol replication capacity (RC) associated with drug resistance diminishes immune injury in vivo, independent of exposure to drugs.
Methods: Virus replication over a single cycle was measured by use of a viral test vector containing patient-derived HIV-1 protease and reverse transcriptase gene segments.
Results: Among 191 recently infected patients, pol RC ranged widely, with only 6% of the variance explained by drug-resistance mutations. Patients infected with a virus with a low pol RC (</=43% of the reference virus) had significantly higher CD4(+) T cell counts at study entry, independent of drug resistance and plasma HIV-1 RNA level, and over time, both before and during combination antiretroviral therapy.
Conclusions: Viral pol RC may influence HIV-1 disease progression by affecting the amount and tissue distribution of viral replication. The pol RC value of 43% may represent a threshold below which HIV-1 has lowered virulence and is less able to deplete CD4(+) T cell counts.
Similar articles
-
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.J Med Virol. 2003 Jan;69(1):1-6. doi: 10.1002/jmv.10269. J Med Virol. 2003. PMID: 12436471
-
Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.J Med Virol. 2005 May;76(1):1-6. doi: 10.1002/jmv.20316. J Med Virol. 2005. PMID: 15778973
-
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.J Med Virol. 2005 Sep;77(1):23-8. doi: 10.1002/jmv.20395. J Med Virol. 2005. PMID: 16032728
-
[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.
-
Antiretroviral therapy for human immunodeficiency virus infection in 1997.West J Med. 1997 May;166(5):319-25. West J Med. 1997. PMID: 9217434 Free PMC article. Review.
Cited by
-
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.BMC Infect Dis. 2005 Nov 2;5:98. doi: 10.1186/1471-2334-5-98. BMC Infect Dis. 2005. PMID: 16266436 Free PMC article.
-
HIV replication capacity is an independent predictor of disease progression in persons with untreated chronic HIV infection.J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):472-9. doi: 10.1097/QAI.0b013e3181cae480. J Acquir Immune Defic Syndr. 2010. PMID: 20032783 Free PMC article.
-
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.J Virol. 2008 May;82(10):4785-92. doi: 10.1128/JVI.02449-07. Epub 2008 Feb 27. J Virol. 2008. PMID: 18305035 Free PMC article.
-
A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells.Viruses. 2021 Mar 4;13(3):404. doi: 10.3390/v13030404. Viruses. 2021. PMID: 33806576 Free PMC article.
-
Is HIV-1 evolving to a less virulent form in humans?Nat Rev Microbiol. 2007 Feb;5(2):141-51. doi: 10.1038/nrmicro1594. Epub 2007 Jan 4. Nat Rev Microbiol. 2007. PMID: 17203103 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials